Recorded Chinese product: 蝎毒注射液蝎毒注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司
主要成分Active Ingredients
- 蝎毒蛋白Xiedu Danbai
药物知识说明
蝎毒蛋白是一种在国家药监局注册认定的药品。标注生产企业为通化卫京药业股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司、通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司、通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 蝎毒注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 通化卫京药业股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司, 通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司, 通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 蝎毒注射液Recorded Chinese product: 蝎毒注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 每安瓿1ml内含10微克蝎毒蛋白。Recorded Chinese description: 每安瓿1ml内含10微克蝎毒蛋白。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 通化卫京药业股份有限公司Chinese legal name: 通化卫京药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字S20060053
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字S20060053
Manufacturer
Chinese legal name: 通化卫京药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字S20060053
生产企业
通化卫京药业股份有限公司(国产)
适应症
本品为慢性持续性疼痛疾病的镇痛剂，用于缓解肩周炎、骨关节病、风湿性或类风湿性关节炎等轻重度疼痛。
用法用量
皮肤过敏试验，取蝎毒注射液1ml(20微克)稀释10倍后，于前臂皮内注射0.05ml，观察15分钟，如注射部位出现直径大于2cm的红斑，或者小于2cm但注射部位周围有荨麻疹，伪足或受试者自感痛痒强烈者为阳性反应。对于皮试反应阳性者应另做对侧前臂的生理盐水对照，以排除假阳性。
不良反应
主要表现为头晕、头痛、恶心，注射部位疼痛。
禁忌
对本品过敏者禁用。
注意事项
1. 严重冠心病患者及其他危重病人慎用。2. 尚无孕妇、哺乳妇女及儿童使用本品的安全性资料。3. 本品适用过程中，若出现皮疹或其它过敏反应，应立即停药观察，或采取必要的处理。
贮藏
2-8 ℃ ，贮存，切勿冻融。
规格
每安瓿1ml内含10微克蝎毒蛋白。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.